Effects of an anti-TSLP antibody on allergen-induced asthmatic responses - PubMed (original) (raw)
Randomized Controlled Trial
. 2014 May 29;370(22):2102-10.
doi: 10.1056/NEJMoa1402895. Epub 2014 May 20.
Paul M O'Byrne, Louis-Philippe Boulet, Ying Wang, Donald Cockcroft, Jeannette Bigler, J Mark FitzGerald, Michael Boedigheimer, Beth E Davis, Clapton Dias, Kevin S Gorski, Lynn Smith, Edgar Bautista, Michael R Comeau, Richard Leigh, Jane R Parnes
Affiliations
- PMID: 24846652
- DOI: 10.1056/NEJMoa1402895
Free article
Randomized Controlled Trial
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses
Gail M Gauvreau et al. N Engl J Med. 2014.
Free article
Abstract
Background: Thymic stromal lymphopoietin (TSLP) is an epithelial-cell-derived cytokine that may be important in initiating allergic inflammation. AMG 157 is a human anti-TSLP monoclonal immunoglobulin G2λ that binds human TSLP and prevents receptor interaction.
Methods: In this double-blind, placebo-controlled study, we randomly assigned 31 patients with mild allergic asthma to receive three monthly doses of AMG 157 (700 mg) or placebo intravenously. We conducted allergen challenges on days 42 and 84 to evaluate the effect of AMG 157 in reducing the maximum percentage decrease in the forced expiratory volume in 1 second (FEV1). We also measured the fraction of nitric oxide in exhaled air, blood and sputum eosinophils, and airway hyperresponsiveness. The primary end point was the late asthmatic response, as measured 3 to 7 hours after the allergen challenge.
Results: AMG 157 attenuated most measures of allergen-induced early and late asthmatic responses. The maximum percentage decrease in the FEV1 during the late response was 34.0% smaller in the AMG-157 group than in the placebo group on day 42 (P=0.09) and 45.9% smaller on day 84 (P=0.02). In addition, patients receiving AMG 157 had significant decreases in levels of blood and sputum eosinophils before and after the allergen challenge and in the fraction of exhaled nitric oxide. There were 15 adverse events in the AMG-157 group, as compared with 12 in the placebo group; there were no serious adverse events.
Conclusions: Treatment with AMG 157 reduced allergen-induced bronchoconstriction and indexes of airway inflammation before and after allergen challenge. These findings are consistent with a key role for TSLP in allergen-induced airway responses and persistent airway inflammation in patients with allergic asthma. Whether anti-TSLP therapeutics will have clinical value cannot be determined from these data. (Funded by Amgen; ClinicalTrials.gov number, NCT01405963.).
Comment in
- TSLP in asthma--a new kid on the block?
Dahlén SE. Dahlén SE. N Engl J Med. 2014 May 29;370(22):2144-5. doi: 10.1056/NEJMe1404737. Epub 2014 May 20. N Engl J Med. 2014. PMID: 24846653 No abstract available.
Similar articles
- Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial. - OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
Gauvreau GM, Boulet LP, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C, Laviolette M, Killian KJ, Davis BE, Larché M, Kipling C, Dua B, Mosesova S, Putnam W, Zheng Y, Scheerens H, McClintock D, Matthews JG, O'Byrne PM. Gauvreau GM, et al. Clin Exp Allergy. 2014 Jan;44(1):29-37. doi: 10.1111/cea.12235. Clin Exp Allergy. 2014. PMID: 24224471 Free PMC article. Clinical Trial. - Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent.
Salter BM, Oliveria JP, Nusca G, Smith SG, Watson RM, Comeau M, Sehmi R, Gauvreau GM. Salter BM, et al. J Allergy Clin Immunol. 2015 Dec;136(6):1636-1644. doi: 10.1016/j.jaci.2015.03.039. Epub 2015 May 9. J Allergy Clin Immunol. 2015. PMID: 25962901 - Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses.
Nakajima S, Kabata H, Kabashima K, Asano K. Nakajima S, et al. Allergol Int. 2020 Apr;69(2):197-203. doi: 10.1016/j.alit.2020.01.001. Epub 2020 Jan 21. Allergol Int. 2020. PMID: 31974038 Review. - Thymic stromal lymphopoietin: a central regulator of allergic asthma.
Watson B, Gauvreau GM. Watson B, et al. Expert Opin Ther Targets. 2014 Jul;18(7):771-85. doi: 10.1517/14728222.2014.915314. Expert Opin Ther Targets. 2014. PMID: 24930783 Review.
Cited by
- Modulating Th2 Cell Immunity for the Treatment of Asthma.
León B, Ballesteros-Tato A. León B, et al. Front Immunol. 2021 Feb 10;12:637948. doi: 10.3389/fimmu.2021.637948. eCollection 2021. Front Immunol. 2021. PMID: 33643321 Free PMC article. Review. - Epithelial Cell Regulation of Allergic Diseases.
Gour N, Lajoie S. Gour N, et al. Curr Allergy Asthma Rep. 2016 Sep;16(9):65. doi: 10.1007/s11882-016-0640-7. Curr Allergy Asthma Rep. 2016. PMID: 27534656 Free PMC article. Review. - The Role of Innate Lymphoid Cells in the Regulation of Immune Homeostasis in Sepsis-Mediated Lung Inflammation.
Akama Y, Satoh-Takayama N, Kawamoto E, Ito A, Gaowa A, Park EJ, Imai H, Shimaoka M. Akama Y, et al. Diagnostics (Basel). 2020 Oct 12;10(10):808. doi: 10.3390/diagnostics10100808. Diagnostics (Basel). 2020. PMID: 33053762 Free PMC article. Review. - Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis.
Shaban Abdelgalil M, Ahmed Elrashedy A, Awad AK, Reda Gad E, Ali MM, Abdelmoez Farahat R, Hassan Shawki B, Abd-ElGawad M. Shaban Abdelgalil M, et al. Sci Rep. 2022 Dec 3;12(1):20905. doi: 10.1038/s41598-022-24763-9. Sci Rep. 2022. PMID: 36463281 Free PMC article. - Out of the orphanage and into the clinic--therapeutic targeting of GATA3.
Bochner BS, Schleimer RP. Bochner BS, et al. N Engl J Med. 2015 May 21;372(21):2060-1. doi: 10.1056/NEJMe1502660. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25980977 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical